• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经口激光显微手术(TLM)治疗声门癌的新病理检查方案介绍:肿瘤学结果的前瞻性分析和配对病例对照研究

Introduction of a New Pathology Workup Protocol for Glottic Cancer Treated With Transoral Laser Microsurgery (TLM): Prospective Analysis of Oncological Outcomes and Matched Case-Control Study.

作者信息

Meulemans Jeroen, Narimani Sara, Hauben Esther, Nuyts Sandra, Laenen Annouschka, Delaere Pierre, Vander Poorten Vincent

机构信息

Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.

Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium.

出版信息

Front Oncol. 2021 May 4;11:685255. doi: 10.3389/fonc.2021.685255. eCollection 2021.

DOI:10.3389/fonc.2021.685255
PMID:34017690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8130557/
Abstract

BACKGROUND/PURPOSE: The value of margin status after TLM for glottic cancer is debatable, due to difficulties in specimen orientation and margin analysis. To reduce these difficulties, we recently introduced a standardized protocol of oriented fixation of TLM specimens. This proved feasible and resulted in high margin evaluability rates and a decreased rate of false positive deep margins, when compared to a historical TLM cohort. For the patients whose specimens were processed according to this protocol, we prospectively analyzed oncological outcomes, identified prognostic factors and assessed the influence of the protocol introduction on outcomes compared with a historical TLM cohort.

METHODS

Ninety-six patients with glottic malignancies treated with TLM were included. Resection specimens were processed according to the new protocol. Descriptive statistics and survival analyses were used to determine oncological outcomes. To assess the effect of the protocol introduction on outcomes, a matched-case-control analysis was performed, using a historical TLM-cohort as controls. The Cox proportional hazards model was used to analyze prognostic effects of patient and treatment characteristics, including the pathology protocol introduction, on overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS) and local recurrence-free survival (LRFS).

RESULTS

Two-year outcomes were favorable: 88.5% OS, 97.0% DSS, and 87.6% LRFS. At multivariable analysis, the presence of multiple positive superficial margins was a negative prognosticator for OS (HR 4.102) and increasing cT classification proved a negative prognosticator for DFS (HR 2.828) and LRFS (HR 2.676). Matched case-control analysis did not reveal a significant difference in oncological outcomes between cohorts. Deep margin status had a strong differential effect for DFS (p-value for interaction = 0.0205) and for LRFS (p-value for interaction = 0.0176) between cohorts, indicating a prognostic effect of deep margin status on both outcomes in the current cohort, but not in the historical cohort.

DISCUSSION/CONCLUSION: The introduction of a new standardized technique of oriented fixation of TLM specimens did not affect oncological outcomes when compared to a historical TLM cohort, but assigned a significant prognostic effect to deep margin status for DFS and LRFS, facilitating the decision making process with regards to planning of second-look procedures, administration of adjuvant radiotherapy or determination of follow-up intensity.

摘要

背景/目的:由于标本定位和切缘分析存在困难,声门癌经支撑喉镜下切除术(TLM)后切缘状态的价值存在争议。为减少这些困难,我们最近引入了一种标准化的TLM标本定向固定方案。与历史TLM队列相比,这一方案被证明是可行的,且切缘评估率高,假阳性深部切缘率降低。对于按照该方案处理标本的患者,我们前瞻性地分析了肿瘤学结局,确定了预后因素,并评估了该方案的引入对结局的影响,并与历史TLM队列进行了比较。

方法

纳入96例行TLM治疗的声门恶性肿瘤患者。切除标本按照新方案进行处理。采用描述性统计和生存分析来确定肿瘤学结局。为评估方案引入对结局的影响,以历史TLM队列作为对照进行配对病例对照分析。采用Cox比例风险模型分析患者和治疗特征(包括病理方案的引入)对总生存(OS)、疾病特异性生存(DSS)、无病生存(DFS)和无局部复发生存(LRFS)的预后影响。

结果

两年的结局良好:OS为88.5%,DSS为97.0%,LRFS为87.6%。多变量分析时,多个阳性浅表切缘的存在是OS的不良预后因素(HR 4.102),cT分级增加被证明是DFS(HR 2.828)和LRFS(HR 2.676)的不良预后因素。配对病例对照分析未显示队列之间肿瘤学结局存在显著差异。深部切缘状态在队列之间对DFS(交互作用p值 = 0.0205)和LRFS(交互作用p值 = 0.0176)有强烈的差异效应,表明深部切缘状态对当前队列的这两种结局均有预后影响,但对历史队列没有影响。

讨论/结论:与历史TLM队列相比,新的标准化TLM标本定向固定技术的引入并未影响肿瘤学结局,但深部切缘状态对DFS和LRFS具有显著的预后影响,有助于在决定二次手术计划、辅助放疗管理或确定随访强度方面的决策过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d8/8130557/68d86727d5e0/fonc-11-685255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d8/8130557/68d86727d5e0/fonc-11-685255-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1d8/8130557/68d86727d5e0/fonc-11-685255-g001.jpg

相似文献

1
Introduction of a New Pathology Workup Protocol for Glottic Cancer Treated With Transoral Laser Microsurgery (TLM): Prospective Analysis of Oncological Outcomes and Matched Case-Control Study.经口激光显微手术(TLM)治疗声门癌的新病理检查方案介绍:肿瘤学结果的前瞻性分析和配对病例对照研究
Front Oncol. 2021 May 4;11:685255. doi: 10.3389/fonc.2021.685255. eCollection 2021.
2
Transoral Laser Microsurgery (TLM) for Glottic Cancer: Prospective Assessment of a New Pathology Workup Protocol.经口激光显微手术(TLM)治疗声门癌:一种新病理检查方案的前瞻性评估
Front Surg. 2020 Aug 28;7:56. doi: 10.3389/fsurg.2020.00056. eCollection 2020.
3
Up-Front and Salvage Transoral Laser Microsurgery for Early Glottic Squamous Cell Carcinoma: A Single Centre Retrospective Case Series.早期声门鳞状细胞癌的 upfront 和挽救性经口激光显微手术:单中心回顾性病例系列
Front Oncol. 2018 May 28;8:186. doi: 10.3389/fonc.2018.00186. eCollection 2018.
4
Oncological and functional outcomes following treatment of T1a glottic squamous cell carcinoma with transoral laser microsurgery.经口激光微创手术治疗 T1a 声门型鳞状细胞癌的肿瘤学和功能学结果。
J Otolaryngol Head Neck Surg. 2022 Jan 20;51(1):2. doi: 10.1186/s40463-021-00553-7.
5
Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma.经口激光显微手术治疗早期声门型鳞状细胞癌切缘预后意义。
Oral Oncol. 2019 Oct;97:105-111. doi: 10.1016/j.oraloncology.2019.08.005. Epub 2019 Aug 29.
6
Impact of Close and Positive Margins in Transoral Laser Microsurgery for Tis-T2 Glottic Cancer.切缘紧邻及阳性对Tis-T2期声门癌经口激光显微手术的影响。
Front Oncol. 2017 Oct 16;7:245. doi: 10.3389/fonc.2017.00245. eCollection 2017.
7
Laryngeal exposure and margin status in glottic cancer treated by transoral laser microsurgery.经口激光显微手术治疗声门癌的喉部暴露及切缘情况
Laryngoscope. 2018 May;128(5):1146-1151. doi: 10.1002/lary.26861. Epub 2017 Sep 12.
8
Evaluation of surgical margin status in patients with early glottic cancer (Tis-T2) treated with transoral CO laser microsurgery, on local control.评估经口CO2激光显微手术治疗的早期声门癌(Tis-T2)患者手术切缘状态对局部控制的影响。
Eur Arch Otorhinolaryngol. 2018 Sep;275(9):2333-2340. doi: 10.1007/s00405-018-5070-9. Epub 2018 Jul 19.
9
Transoral laser microsurgery in early glottic cancer involving the anterior commissure.经口激光显微手术治疗累及前联合的早期声门癌。
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):837-845. doi: 10.1007/s00405-018-5261-4. Epub 2019 Jan 2.
10
Oncological and Surgical Outcomes of Patients Treated by Transoral CO Laser Cordectomy for Early-Stage Glottic Squamous Cell Carcinoma: A Retrospective Chart Review.经口CO2激光声带切除术治疗早期声门鳞状细胞癌患者的肿瘤学和手术结果:一项回顾性病历审查
Ear Nose Throat J. 2021 Feb;100(1_suppl):33S-37S. doi: 10.1177/0145561320911486. Epub 2020 Mar 23.

引用本文的文献

1
European Laryngological Society consensus statement on optimal monitoring schedules after treatment for early glottic cancer: a risk-stratification.欧洲喉科学会关于早期声门癌治疗后最佳监测方案的共识声明:风险分层
Eur Arch Otorhinolaryngol. 2025 Sep;282(9):4699-4710. doi: 10.1007/s00405-025-09609-0. Epub 2025 Aug 4.

本文引用的文献

1
Current indications for adjuvant treatment following transoral laser microsurgery of early and intermediate laryngeal cancer.早期和中期喉癌经口激光显微手术后辅助治疗的当前适应证。
Curr Opin Otolaryngol Head Neck Surg. 2021 Apr 1;29(2):79-85. doi: 10.1097/MOO.0000000000000702.
2
Shrinkage of specimens after CO laser cordectomy: an objective intraoperative evaluation.CO 激光声带切除术标本术后收缩:客观术中评估。
Eur Arch Otorhinolaryngol. 2021 May;278(5):1515-1521. doi: 10.1007/s00405-021-06625-8. Epub 2021 Jan 30.
3
Long-term Oncologic Outcomes of 1188 Tis-T2 Glottic Cancers Treated by Transoral Laser Microsurgery.
经口激光显微手术治疗1188例Tis-T2期声门癌的长期肿瘤学结局
Otolaryngol Head Neck Surg. 2021 Aug;165(2):321-328. doi: 10.1177/0194599820983727. Epub 2021 Jan 5.
4
Prognostic comparison of transoral laser microsurgery for early glottic cancer with or without anterior commissure involvement: A meta-analysis.经口激光显微手术治疗累及或未累及前连合的早期声门型喉癌的预后比较:一项荟萃分析。
Am J Otolaryngol. 2021 Mar-Apr;42(2):102787. doi: 10.1016/j.amjoto.2020.102787. Epub 2020 Dec 9.
5
Transoral Laser Microsurgery (TLM) for Glottic Cancer: Prospective Assessment of a New Pathology Workup Protocol.经口激光显微手术(TLM)治疗声门癌:一种新病理检查方案的前瞻性评估
Front Surg. 2020 Aug 28;7:56. doi: 10.3389/fsurg.2020.00056. eCollection 2020.
6
Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma.经口激光显微手术治疗早期声门型鳞状细胞癌切缘预后意义。
Oral Oncol. 2019 Oct;97:105-111. doi: 10.1016/j.oraloncology.2019.08.005. Epub 2019 Aug 29.
7
Limitations and Opportunities in Open Laryngeal Organ Preservation Surgery: Current Role of OPHLs.开放性喉器官保留手术的局限性与机遇:开放性部分喉切除术的当前作用
Front Oncol. 2019 May 22;9:408. doi: 10.3389/fonc.2019.00408. eCollection 2019.
8
Up-Front and Salvage Transoral Laser Microsurgery for Early Glottic Squamous Cell Carcinoma: A Single Centre Retrospective Case Series.早期声门鳞状细胞癌的 upfront 和挽救性经口激光显微手术:单中心回顾性病例系列
Front Oncol. 2018 May 28;8:186. doi: 10.3389/fonc.2018.00186. eCollection 2018.
9
Three-Dimensional Map of Isoprognostic Zones in Glottic Cancer Treated by Transoral Laser Microsurgery as a Unimodal Treatment Strategy.经口激光显微手术作为单峰治疗策略治疗声门癌的等预后区三维图谱。
Front Oncol. 2018 May 22;8:175. doi: 10.3389/fonc.2018.00175. eCollection 2018.
10
Prognostic value of age, subglottic, and anterior commissure involvement for early glottic carcinoma treated with CO laser transoral microsurgery: a retrospective, single-center cohort study of 261 patients.年龄、声门下及前联合受累对接受CO2激光经口显微手术治疗的早期声门癌的预后价值:一项对261例患者的回顾性单中心队列研究
Eur Arch Otorhinolaryngol. 2018 May;275(5):1199-1210. doi: 10.1007/s00405-018-4890-y. Epub 2018 Feb 13.